Readly International AB (publ) (FRA:5GS1)

Intra-Cellular Therapies Revenue

Readly International AB had revenue of 182.50M SEK in the quarter ending March 31, 2025, with 4.92% growth. This brings the company's revenue in the last twelve months to 730.68M, up 7.66% year-over-year. In the year 2024, Readly International AB had annual revenue of 722.13M with 8.91% growth.

• Revenue (ttm): 730.68M SEK
• Revenue Growth: +7.66%
• P/S Ratio: n/a
• Revenue / Employee: 8.12M SEK
• Employees: 90
• Market Cap: n/a

Revenue Chart

* This company reports financials in SEK.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	722.13M	59.06M	8.91%
Dec 31, 2023	663.07M	82.33M	14.18%
Dec 31, 2022	580.74M	120.01M	26.05%
Dec 31, 2021	460.73M	110.90M	31.70%
Dec 31, 2020	349.83M	86.47M	32.83%